Nicotinamide for the treatment of heart failure with preserved ejection fraction-Reference-Cited by-同舟云学术

Nicotinamide for the treatment of heart failure with preserved ejection fraction

Published:2021-02-10 Issue:580 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Abdellatif Mahmoud¹^ORCID,Trummer-Herbst Viktoria¹^ORCID,Koser Franziska²,Durand Sylvère³⁴,Adão Rui¹⁵,Vasques-Nóvoa Francisco⁵^ORCID,Freundt Johanna K.²,Voglhuber Julia¹⁶^ORCID,Pricolo Maria-Rosaria⁷^ORCID,Kasa Michael¹^ORCID,Türk Clara⁸⁹^ORCID,Aprahamian Fanny³⁴,Herrero-Galán Elías⁷^ORCID,Hofer Sebastian J.¹⁰^ORCID,Pendl Tobias¹⁰^ORCID,Rech Lavinia¹^ORCID,Kargl Julia¹¹^ORCID,Anto-Michel Nathaly¹,Ljubojevic-Holzer Senka¹⁶^ORCID,Schipke Julia¹²,Brandenberger Christina¹²^ORCID,Auer Martina¹³¹⁴,Schreiber Renate¹⁰^ORCID,Koyani Chintan N.¹^ORCID,Heinemann Akos¹¹^ORCID,Zirlik Andreas¹,Schmidt Albrecht¹,von Lewinski Dirk¹^ORCID,Scherr Daniel¹,Rainer Peter P.¹⁶^ORCID,von Maltzahn Julia¹⁵,Mühlfeld Christian¹²,Krüger Marcus⁸⁹^ORCID,Frank Saša⁶¹³,Madeo Frank⁶¹⁰,Eisenberg Tobias⁶¹⁰^ORCID,Prokesch Andreas⁶¹³¹⁴^ORCID,Leite-Moreira Adelino F.⁵,Lourenço André P.⁵^ORCID,Alegre-Cebollada Jorge⁷^ORCID,Kiechl Stefan¹⁶¹⁷^ORCID,Linke Wolfgang A.²^ORCID,Kroemer Guido³⁴¹⁸¹⁹²⁰^ORCID,Sedej Simon¹⁶²¹^ORCID

Affiliation:

1. Department of Cardiology, Medical University of Graz, Graz 8036, Austria.

2. Institute of Physiology II, University of Münster, Münster 48149, Germany.

3. Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif 94805, France.

4. Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Institut Universitaire de France, Paris 75006, France.

5. Department of Surgery and Physiology, Cardiovascular Research and Development Centre (UnIC), Faculty of Medicine, University of Porto, Porto 4200-319, Portugal.

6. BioTechMed Graz, Graz 8010, Austria.

7. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.

8. Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, Cologne 50931, Germany.

9. Center for Molecular Medicine (CMMC), University of Cologne, Cologne 50931, Germany.

10. Institute of Molecular Biosciences, University of Graz, NAWI Graz, Graz 8010, Austria.

11. Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Graz 8010, Austria.

12. Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover 30625, Germany.

13. Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Graz 8010, Austria.

14. Division of Cell Biology, Histology and Embryology, Medical University of Graz, Graz 8010, Austria.

15. Leibniz Institute on Aging, Jena 07745, Germany.

16. Department of Neurology, Medical University of Innsbruck, Innsbruck 6020, Austria.

17. VASCage, Research Centre for Promoting Vascular Health in the Ageing Community, Innsbruck 6020, Austria.

18. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris 75015, France.

19. Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou 215000, China.

20. Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Solna 17164, Sweden.

21. Faculty of Medicine, University of Maribor, Maribor 2000, Slovenia.

Abstract

The NAD + precursor nicotinamide improves diastolic dysfunction caused by aging, hypertension, or metabolic syndrome in rodents.

Funder

Agence Nationale de la Recherche

Fundação para a Ciência e a Tecnologia

Bundesministerium für Bildung und Forschung

Austrian Science Fund

Instituto de Salud Carlos III

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference64 articles.

1. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study

2. Epidemiology of heart failure with preserved ejection fraction

3. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure

4. An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology

5. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of cardiac mitochondrial complex I persulfidation impairs NAD+ homeostasis in aging;Redox Biology;2024-02

2. Senescent hearts from male Ts65Dn mice exhibit preserved function but altered size and nicotinamide adenine dinucleotide pathway signaling;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2024-02-01

3. The therapeutic perspective of NAD+ precursors in age-related diseases;Biochemical and Biophysical Research Communications;2024-02

4. NAD in pathological cardiac remodeling: Metabolic regulation and beyond;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

5. Efficacy of Nicotinamide Adenine Dinucleotide in Heart Failure Patients: A randomized, double-blind, placebo-control clinical trial;2023-12-28